Jet Biofil released its 2026 interim report. Total operating revenue was 277 million yuan, and net profit attributable to the parent company was 20.8166 million yuan, down 55.08% from the same period last year, a decrease of 25.5221 million yuan. Net cash inflow from operating activities was 35.1043 million yuan, down 58.29% year-on-year. The company's asset-liability ratio was 30.28%, gross margin was 39.41%, ROE was 1.74%, and diluted earnings per share was 0.15 yuan. The number of shareholders was 8,134, and the top ten shareholders held 50.52% of the total share capital.
Guangzhou Jet Bio-Filtration Co LtdNet profit fell 55.08% year-on-year, with operating cash flow down 58.29%.